SBC Medical Group Holdings Incorporated SBC
- Market cap
- $488.5M
- P/E
- 10.4×
Follow SBC
Target Price Range
Analyst price targets
Free account| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| — | — | — | — | — | — | 9.95 | 10.15 | 5.21 | 2.62 |
Analyst estimates 2026–2028 Powerpack |
Low Price
|
||
| — | — | — | — | — | — | 10.61 | 11.56 | 36.52 | 7.00 |
High Price
|
|||
| — | — | — | — | — | — | 2 | 2 | 863 | 863 |
Employees
|
|||
| — | — | — | — | — | — | 0 | 97 | 0 | 0 |
Revenue/Emp
|
|||
| — | — | — | — | — | — | — | 194 | 205 | 174 |
Revenue
|
|||
| — | — | — | — | — | — | — | 70.94% | 75.97% | 73.32% |
Gross Margin
|
|||
| — | — | — | — | — | — | 1 | 74 | 73 | 82 |
EBT
|
|||
| — | — | — | — | — | — | 0.00% | 38.02% | 35.76% | 47.27% |
EBT Margin
|
|||
| — | — | — | — | — | — | 1 | 39 | 47 | 51 |
Net Income
|
|||
| — | — | — | — | — | — | — | 12 | 4 | 3 |
Depreciation
|
|||
| — | — | — | — | — | — | 0.00 | 2.05 | 2.13 | 1.69 |
Revenue/Sh
|
|||
| — | — | — | — | — | — | 0.16 | 0.41 | 0.48 | 0.50 |
Earnings/Sh
|
|||
| — | — | — | — | — | — | (0.17) | 0.54 | 0.21 | 0.24 |
Cash Flow/Sh
|
|||
| — | — | — | — | — | — | 0.00 | (0.03) | (0.04) | 0.05 |
Capex/Sh
|
|||
| — | — | — | — | — | — | (0.17) | 0.50 | 0.18 | 0.29 |
Free CF/Sh
|
|||
| — | — | — | — | — | — | (1.25) | 1.53 | 2.02 | 2.56 |
Book Value/Sh
|
|||
| — | — | — | — | — | — | 3 | 94 | 97 | 103 |
Shares
|
|||
| — | — | — | — | — | — | — | 26.38 | 11.44 | 8.80 |
PE Ratio
|
|||
| — | — | — | — | — | — | — | 0.00 | 2.61 | 2.56 |
PS Ratio
|
|||
| — | — | — | — | — | — | — | 7.07 | 2.75 | 1.69 |
PB Ratio
|
|||
| — | — | — | — | — | — | — | 0.00 | 2.04 | 1.86 |
EV/Sales
|
|||
| — | — | — | — | — | — | — | 18.30 | 24.36 | 10.84 |
EV/FCF
|
|||
| — | — | — | — | — | — | 0 | 51 | 21 | 25 |
Op' Cash Flow
|
|||
| — | — | — | — | — | — | — | (3) | (3) | 5 |
Capex
|
|||
| — | — | — | — | — | — | 0 | 48 | 17 | 30 |
FCF
|
|||
| — | — | — | — | — | — | 0 | 73 | 123 | 170 |
Working Cap'
|
|||
| — | — | — | — | — | — | — | 13 | 7 | 43 |
Total Debt
|
|||
| — | — | — | — | — | — | 0 | (90) | (118) | (121) |
Net Debt
|
|||
| — | — | — | — | — | — | (3) | 144 | 195 | 263 |
Sh' Equity
|
|||
| — | — | — | — | — | — | 0.00% | 20.79% | 17.76% | 15.77% |
ROA
|
|||
| — | — | — | — | — | — | 0.00% | 81.85% | 57.38% | 29.67% |
ROIC
|
|||
| — | — | — | — | — | — | 0.00% | 56.06% | 27.51% | 22.25% |
ROE
|
|||
SBC Medical Group Holdings Incorporated peers in Consulting Services
| Company | Market cap | P/E | Compare |
|---|---|---|---|
| ROMA Roma Green Finance Limited | $517.4M | — | Compare |
| CRAI Charles River Associates | $1.0B | 21.4× | Compare |
| FORR Forrester Research, Inc. | $220.3M | 0.0× | Compare |
| LAWR Robot Consulting Co., Ltd. | $172.4M | — | Compare |
| Company | Market cap | P/E | Compare |
|---|---|---|---|
| ICFI ICF International, Inc. | $1.5B | 17.2× | Compare |
| RGP Resources Connection, Inc. | $130.1M | 0.0× | Compare |
| HURN Huron Consulting Group Inc. | $2.5B | 23.2× | Compare |
| EFTY Etoiles Capital Group Co., Ltd. | $75.1M | — | Compare |
SBC Medical Group Holdings Incorporated (SBC) key facts
- SBC Medical Group Holdings Incorporated (SBC) is a Consulting Services company in the Industrials sector, listed on Nasdaq.
- SBC Medical Group Holdings Incorporated’s revenue for fiscal 2025 (year ended December 2025) was $173.6 million, down 15.5% from fiscal 2024.
- As of September 25, 2026, SBC traded at $4.90, a market capitalization of $488.5 million.
- Return on equity was 22.3% and debt-to-equity 0.14.
SBC Medical Group Holdings Incorporated (SBC) Latest News
30 Aug
SBC Medical Group Holdings Incorporated re-accelerates growth with a 32% surge in EBITDA for Q2. 32% Q2 EBITDA surge signals strong financial momentum that can significantly lift valuation and investor outlook.
20 Aug
SBC Medical Group Holdings Inc (SBC) Q2 2026 earnings call highlights show profit growth outpacing prior periods. Q2 2026 profit growth exceeding prior levels points to stronger financial results and improved investor outlook for SBC.
SBC Medical Group Holdings Incorporated held its Q2 2026 earnings call to discuss financial results and operations. Q2 2026 earnings call updates financial performance and outlook with moderate effects on stock trajectory.
19 Aug
SBC Medical Group Holdings Incorporated reported re-accelerated Q2 growth with EBITDA surging 32%. Q2 EBITDA growth of 32% signals stronger profitability that can lift near-term valuation and sentiment.
SBC Medical Group Holdings Incorporated's 2Q26 results demonstrate resumed growth with continued growth measures in place. 2Q26 results showing resumed growth may moderately influence SBC's financial performance and investor sentiment.
14 Aug
SBC Medical Group Holdings Incorporated conducted its Q2 2026 earnings call. Earnings calls deliver financial updates that moderately shape near-term market views.
13 Aug
SBC Medical Group Holdings Incorporated held its Q2 earnings call, presenting financial results, operational updates and forward outlook. Q2 earnings call discloses key financial metrics and strategic guidance that can materially shift investor views and stock trajectory.
SBC Medical Group Holdings Incorporated reported second quarter 2026 financial results. Quarterly financial results update company performance metrics and may shift near-term investor views.
8 Jul
SBC Medical launches Japan's first specialized men's beard hair removal clinic, establishing a scalable, capital-efficient growth platform. Launch of first specialized clinic creates new scalable growth channel for SBC Medical in Japan.
20 May
Emerging Growth Research released its Q1 2026 quarterly update on SBC Medical Group Holdings, upgrading the rating to Buy and raising the price target to $10.00. Analyst buy rating upgrade with higher price target moderately lifts near-term investor sentiment and trading activity for SBC.
19 May
SBC Medical Group Holdings Incorporated increases focus on non-aesthetic specialties and reports encouraging early results from multi-brand strategy. Strategic pivot to non-aesthetic areas with positive multi-brand results supports moderate gains in operations and positioning.
14 May
SBC Medical Group Holdings Inc (SBC) Q1 2026 earnings call highlights strategies for navigating revenue challenges amid operational updates. Q1 2026 earnings highlights detail revenue navigation strategies, poised to significantly influence SBC's financial trajectory and investor sentiment.
SBC Medical Group Holdings Incorporated announced its first quarter 2026 financial results. Quarterly earnings announcements like Q1 2026 results significantly impact financial performance metrics and investor sentiment.
SBC Medical Group Holdings Incorporated released highlights from its Q1 earnings call. Q1 earnings call highlights affect financial performance and investor sentiment moderately.
27 Apr
SBC Medical Group Holdings Incorporated announces full-scale rollout of aesthetic healthcare-focused interpretation app 'Talk Bridge' across all Shonan Beauty Clinic locations. Full-scale app rollout across all clinics represents a major strategic tech integration improving service for international patients and operational efficiency.
21 Apr
SBC Medical Group Holdings Incorporated closed its previously announced secondary public offering of 3.1 million shares of common stock. Closing a secondary offering of 3.1 million shares boosts liquidity and market sentiment without diluting shareholders or raising new capital for the company.
19 Apr
SBC Medical Group Holdings Incorporated announced the pricing of a secondary public offering of 3.1 million shares of common stock. Secondary public offering increases share float and liquidity, moderately influencing short-term market sentiment and stock performance.
8 Apr
SBC Medical Group Holdings (SBC) reported a miss on paper, but deeper analysis uncovers stronger underlying factors and potential positives beyond surface results. Earnings miss noted, but mitigating positives limit impact to moderate influence on financials and sentiment.
6 Apr
Emerging Growth Research reiterates Buy-Extended rating on SBC Medical Group Holdings, Inc. with $9.00 price target following Q4:25 quarterly update. Reiterated Buy-Extended rating with $9.00 price target post-Q4:25 update boosts investor sentiment and could significantly drive stock performance.
SBC Medical Group Holdings Incorporated reports average revenue per customer visit trending upward, with expected benefits from expansions in wellness and longevity areas. Upward revenue per visit trend and strategic expansions in high-growth wellness and longevity sectors signal significant positive impact on financial performance and market positioning.
2 Apr
SBC Medical Group Holdings Inc (SBC) Q4 2025 earnings call highlights strategic expansion initiatives alongside key financial and operational updates. Strategic expansion in Q4 2025 earnings call signals major growth moves altering SBC's trajectory and investor sentiment.
31 Mar
PRISM MarketView publishes exclusive Q&A with SBC Medical Group Holdings CEO Yoshiyuki Aikawa discussing growth strategy, U.S. expansion, and improving unit economics. CEO's exclusive Q&A outlines major growth strategies, U.S. expansion plans, and unit economics improvements that could significantly boost SBC's future performance and investor sentiment.
27 Mar
SBC Medical Group Holdings Incorporated announced fourth quarter and full year 2025 financial results. Financial results announcements directly shape investor sentiment, stock valuation, and future performance expectations for SBC.
SBC Medical Group Holdings Incorporated released Q4 earnings call highlights covering financial results, operational updates, and future outlook. Q4 earnings highlights impact financial performance and market sentiment but face offsetting factors like market conditions.
24 Mar
SBC Medical Group Holdings Incorporated (SBC) announces SBC Wellness 2.0, its next-generation wellness strategy. SBC Wellness 2.0 launch marks a major strategic advancement in wellness offerings, likely enhancing competitive positioning and investor sentiment.
16 Mar
SBC Medical Group Holdings Incorporated announces the opening of its brand flagship NEO Skin Clinic in Ginza. Flagship clinic launch in prime Ginza location signals major expansion, enhancing brand prestige and revenue potential.
13 Mar
SBC Medical Group Holdings Incorporated (SBC) to announce Q4 and full-year 2025 financial results. Earnings announcements directly impact financial performance visibility and market sentiment.
2 Mar
SBC Medical Group Holdings Incorporated (SBC) appointed Sheng-FU Hsiao as CTO to leverage medical big data from 283 global locations and 6.63 million annual patient visits for building scalable, AI-driven medical management infrastructure. Appointing a CTO to harness massive global big data for AI infrastructure represents a major strategic move enhancing SBC's scalability and competitive edge in medical management.
1 Feb
SBC Medical-Supported Medical Corporation Nasukai has entered into a strategic alliance with Daibi Medical Aesthetics. This partnership aims to enhance service offerings and expand market reach in the medical aesthetics sector, leveraging both companies' strengths to improve patient care and operational efficiency. The strategic alliance is expected to significantly enhance SBC's market positioning and service capabilities in the growing medical aesthetics industry.
26 Jan
SBC Medical Group Holdings Incorporated (SBC) has been highlighted in Zacks Small Cap Research's best ideas for 2026, indicating strong potential for growth and investment interest. The report emphasizes SBC's strategic initiatives and market positioning, suggesting that the company is well-placed to capitalize on upcoming opportunities in the healthcare sector. Analysts are optimistic about SBC's future performance, driven by innovative solutions and a robust operational framework. SBC's inclusion in a best ideas report signals significant investor interest and potential for strategic growth.